78
Views
0
CrossRef citations to date
0
Altmetric
Erratum

Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways [Erratum]

Pages 499-500 | Published online: 31 Jan 2019
This article refers to:
Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways

Ren H, Li Y, Chen Y, Wang L. Drug Des Devel Ther. 2019; 13: 285–290.

On page 289, and Notes should read as follows:

Figure 4 Endostatin inhibits the expression of α-SMA, RhoA, and ROCK1 at mRNA level.

Notes: Transcript levels of α-SMA, RhoA, and ROCK1 were analyzed by RT-PCR (AC). Endostatin significantly suppressed the expressions of α-SMA, RhoA, and ROCK1 at mRNA level in HSC-T6 cells. Data are expressed as mean ± SD. *P<0.05, **P<0.01 (n=3 per group).
Abbreviations: α-SMA, α-smooth muscle actin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSC, hepatic stellate cell; RhoA, ras homolog gene family, member A; ROCK1, Rho-associated protein kinase 1; RT-PCR, real-time PCR.
Figure 4 Endostatin inhibits the expression of α-SMA, RhoA, and ROCK1 at mRNA level.